NeoPharm Announces Fiscal 2006 Conference Call and Update on CINTREDEKIN BESUDOTOX

WAUKEGAN, Ill.--(BUSINESS WIRE)--NEOPHARM, Inc. (Nasdaq:NEOL) today announced that Guillermo Herrera, President and Chief Executive Officer, and other members of senior management, will hold a conference call and webcast to discuss fourth-quarter and full-year 2006 operating results and provide an update on CINTREKIN BESUDOTOX.
MORE ON THIS TOPIC